Edwards Lifesciences Corporation
$93.0M 70,149 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Abbott Laboratories
Abbott Laboratories reported $91,733,934.41 across General Payments, Research, and Ownership to 292,558 physicians and teaching hospitals across 302,960 transactions.
- $91.7M
- All-tracks total
- 302,960
- Transactions
- 292,558
- Recipients
- −$4.1M
- General Payments vs PY2023
Abbott Laboratories reported $91,733,934.41 across all CMS Open Payments tracks (General + Research + Ownership) to 292,558 physicians and teaching hospitals in Program Year 2024 - ranking #30 of 1,925 reporting manufacturers (0.7% of the all-tracks industry total); General Payments alone were $38,295,144.91, averaging $313.56 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer abbott-laboratories Abbott Laboratories
$91.7M · #30/1,925 · 0.7% industry · PY2024
- TOT $91.7M
- RANK #30
- SHARE 0.7%
- TXN 302,960
- RCP 292,558
- CAT 11
- GEN $38.3M
- ΔGEN −$4.1M
- TOP1 3.3%
- PY 2024
Volume peers
Nearest volume peer: Edwards Lifesciences Corporation ($93.0M)
Abbott Laboratories sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Abbott Laboratories's CMS-reported General Payments decreased by $4.1M (−9.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ABBOTT LABORATORIESPY2023: ABBOTT LABORATORIESPY2024: Abbott Laboratories. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $42,380,026.02
- PY2024
- $38,295,144.91
What the Data Shows for Abbott Laboratories
Averaging $302.79 per transaction and $313.56 per recipient, Abbott Laboratories's Program Year 2024 total comes to $91,733,934.41 across 302,960 transactions and 292,558 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #30 of 1,925 companies, representing 0.7% of all industry payments reported nationwide for the year.
The 11-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $10.3M, accounting for 27.0% of this company's General Payments and 5,163 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Abbott Laboratories's 11-category general-payment breakdown at $10.3M, 27.0% of the reported total.
Abbott Laboratories reports 11 general-payment categories - the top three are Consulting Fee (27.0%), Food and Beverage (26.8%), and Travel and Lodging (17.5%). The remaining 8 categories make up 28.7% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Abbott Laboratories files across 11 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Abbott Laboratories divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $10.3M | 5,163 | 27.0% |
| Food and Beverage | $10.2M | 257,401 | 26.8% |
| Travel and Lodging | $6.7M | 25,026 | 17.5% |
| Compensation for Services Other Than Consulting | $4.8M | 2,594 | 12.4% |
| Grant | $2.7M | 450 | 7.0% |
| Education | $1.1M | 1,111 | 2.8% |
| Space Rental or Facility Fees | $958.2K | 252 | 2.5% |
| Royalty or License | $941.3K | 10 | 2.5% |
| Long-Term Medical Supply or Device Loan | $450.7K | 533 | 1.2% |
| Charitable Contribution | $123.8K | 9 | 0.3% |
| Debt Forgiveness | $18.0K | 9 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,907,907.85 (7.6%) of $38,295,144.91 in this company's General Payments records across 74,531 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Abbott Laboratories
The five named recipients with the highest reported General Payments from this company
- 1
Washington Hospital Center
$1,259,500.00 across 22 reported transactions
- 2
Claudio Feler
$644,233.92 across 4 reported transactions
- 3
Robert J Alpern
$395,334.10 across 15 reported transactions
- 4
Montefiore Medical Center
$342,239.83 across 18 reported transactions
- 5
St. Francis Hospital
$266,600.00 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Abbott Laboratories's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Abbott Laboratories.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Abbott Laboratories.
Showing 6 of 1,924 companies with CMS-reported payment data.
Celgene Corporation
$88.9M 60,850 recipients
Compare payment profiles
Zimmer Biomet Holdings, Inc.
$88.6M 33,496 recipients
Compare payment profiles
CSL Behring
$88.2M 27,644 recipients
Compare payment profiles
Genzyme Corporation
$97.0M 182,526 recipients
Compare payment profiles
Incyte Corporation
$84.4M 77,737 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.